Invested Business? Invest in Marketing
With so much research and development taking place in the early stages of your...
read moreSimple blood-based test will help reduce screening failure in clinical trials and assist drug discovery 22nd July 2016, Oxford, UK. Cytox Ltd, an innovative developer of assays for risk assessment and prediction of dementia, has announced the launch of its research use variaTECT™ genetic biomarker test for assessing Alzheimer’s disease (AD) risk. The variaTECT™ SNP…
read more
